Why the study?
Do therapies like colchicine and anakinra reduce the risk of recurrence in paediatric patients with recurrent pericarditis?
Do therapies like colchicine and anakinra reduce the risk of recurrence in paediatric patients with recurrent pericarditis?
In pediatric patients with recurrent pericarditis, colchicine and anakinra are associated with a significant reduction in recurrences, whereas corticosteroids are associated with increased recurrences and side effects.
No takes yet. Share an insight, caveat, or question.
Colchicine and anakinra were associated with fewer recurrences in pediatric recurrent pericarditis; should not change practice without randomized confirmation.
Imazio et al. (2016) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: